2,135
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus

, , , & ORCID Icon

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Miguel Turégano-Yedro, Eva Trillo-Calvo, Fernando Navarro i Ros, José David Maya-Viejo, Cruz González Villaescusa, Jose Maria Echave Sustaeta, Esperanza Doña & Bernardino Alcázar Navarrete. (2023) Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2887-2893.
Read now
Fernando González-Torralba, Adolfo Baloira, Araceli Abad, Antonia Fuster, Juan Luis García-Rivero, Patricia García-Sidro, Eduardo Márquez-Martín, Marta Palop, Néstor Soler & José Luis Velasco. (2022) FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1005-1015.
Read now
Adolfo Baloira, Araceli Abad, Antonia Fuster, Juan Luis García Rivero, Patricia García-Sidro, Eduardo Márquez-Martín, Marta Palop, Néstor Soler, J L Velasco & Fernando González-Torralba. (2021) Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1021-1033.
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
José Luis López-Campos, Bernardino Alcázar Navarrete, Juan Antonio Riesco Miranda, Borja G Cosío, Juan P de-Torres, Bartolomé Celli, Carlos A Jiménez-Ruiz & Ciro Casanova Macario. (2020) A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1801-1811.
Read now

Articles from other publishers (8)

Radhika R, Beena Thomas, Ahmed Rafad, Jerin James, Mekha Monsi Chenthiyethu & Ruben Thomas Lal. (2022) A study on the safety profile and clinical outcomes in patients using tulobuterol transdermal patch as an add on therapy in stable chronic obstructive pulmonary disease. IP Indian Journal of Immunology and Respiratory Medicine 7:1, pages 16-20.
Crossref
Sarah E. Petite, Michael W. Hess & Herbert Wachtel. (2020) The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease. Journal of Pharmacy Technology 37:2, pages 95-106.
Crossref
Jordi Giner DonaireDavid Díaz PérezCarme HernándezRoberto Cabestre. (2020) Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:3, pages 153-160.
Crossref
Roland Buhl, Ana-Maria Tanase, Motoi Hosoe, Weihua Cao, Ivan Demin, Christian Bartels, Jürgen Jauernig, Dominik Ziegler, Francesco Patalano, Bettina Hederer, Frank Kanniess & Hanns-Christian Tillmann. (2020) A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma. Pulmonary Pharmacology & Therapeutics 62, pages 101919.
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R Celli. (2020) Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis. Chronic Respiratory Disease 17, pages 147997311990123.
Crossref
A. A. Vizel & I. Yu. Vizel. (2018) 12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review. Medical Council:15, pages 116-122.
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. Chest 154:2, pages 242-248.
Crossref
Marc Miravitlles, Seungjae BaekVatsal VithlaniRahul Lad. (2018) Optimal Bronchodilation for COPD Patients: Are All Long-Acting β 2 -Agonist/Long-Acting Muscarinic Antagonists the Same? . Tuberculosis and Respiratory Diseases 81:3, pages 198.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.